Exploiting research conducted at Kyoto Prefecture University of Medicine, Aurion Biotech is focusing on therapies that can restore vision.

The metaverse technology developer has now pushed its overall funding past $750m since emerging out of Cambridge’s Department of Computer Science and Technology.

Repsol led the waste-to-biofuel technology provider’s largest round in four years and plans to collaborate with it on Iberian projects.

GV returned for the brain scanning technology provider’s series D round at a $1.2bn valuation, boosting its overall funding to about $250m.

Burda Principal Investments was among the participants that backed the virtual private network provider at a $1.6bn valuation.

The oncology analytics software developer received a top-up from investors including NEC Corporation at a unicorn valuation.

SoftBank Vision Fund 2 co-led a $150m round to allow the metaverse technology developer to push its overall funding past $750m.

Pfizer Ventures was among the investors in Triana’s series A round and has taken a board seat at the molecular glue platform developer.

Porsche, Baker Hughes and majority shareholder AME all invested in the round, which will support the deployment of HIF's hydrogen fuel projects.

The cryptocurrency exchange’s US spinoff pulled in a nine-figure sum from investors like Circle Ventures at a post-money valuation of $4.7bn.